Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1998
11/12/1998WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT
11/12/1998WO1998027966A3 Encapsulated cells producing antibodies
11/12/1998WO1997039128A3 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
11/12/1998CA2289125A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998CA2289124A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998CA2289025A1 Human serine protease precursor
11/12/1998CA2289008A1 Estrenes
11/12/1998CA2288986A1 Beta-lactam inhibitors of coa-it
11/12/1998CA2288017A1 Methods for eosinophil depletion and compositions therefor
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877030A2 EPO primary response gene 1,(EPRG1)
11/11/1998EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998EP0877018A1 Sulfonylaminocarboxylic acids
11/11/1998EP0876813A1 Composition containing a microorganism culture medium
11/11/1998EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv
11/11/1998EP0876487A1 Mammalian cx 3?c chemokine genes
11/11/1998EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
11/11/1998EP0876482A1 Il-13 receptor polypeptide
11/11/1998EP0876398A1 Induction of immune response against desired determinants
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998EP0876392A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
11/11/1998EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998EP0876153A2 Medical use of proteases
11/11/1998EP0876143A2 TUMOR NECROSIS FACTOR ALPHA (TNF-$g(a)) INHIBITING PHARMACEUTICALS
11/11/1998EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198671A Green porphyrins as immunomodulators
11/11/1998CN1198669A Use of aminoadamantane compound as immunoregulators
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834594 Polyethylene-protein conjugates
11/10/1998US5834512 Administering 6,9-octadecadienoic acid, 8,11-eicosadienoic acid and/or 5,8,11-eicosatrienoic acid
11/10/1998US5834508 Ketone derivatives
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834487 Inhibition of 26S and 20S proteasome by indanones
11/10/1998US5834474 Enantiomerically pure B--D--dioxolane nucleosides with selective anti-hepatitus B virus activity
11/10/1998US5834441 Introducing a genetic sequence into a host cell
11/10/1998US5834425 Composite of lectin and epidermal growth factor domains, treatment of pathological leukocyte mediated inflammation
11/10/1998US5834419 Chemokine binding protein and methods of use therefor
11/10/1998US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus
11/10/1998US5834238 Human GTP binding protein
11/10/1998US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders
11/10/1998US5834015 Protein-lipid vesicles and autogenous vaccine comprising the same
11/10/1998US5833996 Treatment of psoriasis using dead cells of Mycobacterium vaccae
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998US5833989 Complement receptor type 1 protein was encoded by plasmides having no more three inserted short consensus repeats nucleotide; use in inflammatory, brain, nevous system and immune disorders
11/10/1998US5833987 Treatment of T cell mediated autoimmune disorders
11/10/1998US5833984 Composition and method for preventing and treating inflammation with Immunoglobulin A
11/10/1998US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/09/1998CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049305A1 Chimeric opg polypeptides
11/05/1998WO1998049303A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998WO1998049302A1 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998049292A2 Polypeptides associated with activator receptors and their biological applications
11/05/1998WO1998049193A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049138A2 Vitamin d3 analogs with bis c-20 side chains
11/05/1998WO1998048809A1 Use of immunomodulating agents
11/05/1998WO1998048805A1 Pharmaceutical composition for supressing type 2 helper t cell immune response
11/05/1998WO1998048802A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
11/05/1998WO1998042737A3 Peptides for the treatment of systemic lupus erythematosus
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998034602A3 Mediation of cytokines by melanin
11/05/1998CA2815903A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2720332A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2288433A1 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998CA2288351A1 Chimeric opg polypeptides
11/05/1998CA2288343A1 Secreted proteins and polynucleotides encoding them
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287916A1 Polypeptides associated with activator receptors and their biological applications
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0874851A2 Macrocyclic compounds made from suboxide units
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
11/04/1998EP0874843A1 Novel substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases
11/04/1998EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors
11/04/1998EP0874815A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
11/04/1998EP0874800A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
11/04/1998EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998EP0874635A1 Non-immunogenic and toleragenic platelet and red blood cell compositions
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998CN1198101A Compositions and their uses
11/04/1998CN1198099A Acellular pertussis vaccines and method of preparation thereof
11/04/1998CN1198098A Use of muteins of wild-type cytokines as immunogens
11/04/1998CN1197639A Rapamycin formulations for oral administration
11/03/1998US5831094 Difluoro statone antiviral analogs
11/03/1998US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998US5831048 Grb3-3 cDNA and polypeptides
11/03/1998US5830994 Peptide derivatives of alpha-MSH and their application
11/03/1998US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830898 Enantiomerically pure β-di-dioxolane-nucleosides with selective anti-hepatitis B virus activity
11/03/1998US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830877 Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
1 ... 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 ... 1172